| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |